Global Prostate Cancer Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Prostate Cancer Testing market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22650 million by 2030 with a CAGR of 7.3% during review period.
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
The Global Info Research report includes an overview of the development of the Prostate Cancer Testing industry chain, the market status of Hospital Associated Labs (PSA Tests, CTC Tests), Independent Diagnostic Laboratories (PSA Tests, CTC Tests), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Prostate Cancer Testing.
Regionally, the report analyzes the Prostate Cancer Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Prostate Cancer Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Prostate Cancer Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Prostate Cancer Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PSA Tests, CTC Tests).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Prostate Cancer Testing market.
Regional Analysis: The report involves examining the Prostate Cancer Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prostate Cancer Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Prostate Cancer Testing:
Company Analysis: Report covers individual Prostate Cancer Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prostate Cancer Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Associated Labs, Independent Diagnostic Laboratories).
Technology Analysis: Report covers specific technologies relevant to Prostate Cancer Testing. It assesses the current state, advancements, and potential future developments in Prostate Cancer Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Prostate Cancer Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Prostate Cancer Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Market segment by Application
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Market segment by players, this report covers
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prostate Cancer Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prostate Cancer Testing, with revenue, gross margin and global market share of Prostate Cancer Testing from 2019 to 2024.
Chapter 3, the Prostate Cancer Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Prostate Cancer Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Prostate Cancer Testing.
Chapter 13, to describe Prostate Cancer Testing research findings and conclusion.